CHARACTERISTICS OF THE BINDING OF THE ANTIHYPERTENSIVE AGENT MOXONIDINE TO ALPHA-2-ADRENOCEPTORS IN RAT-BRAIN MEMBRANES
- 1 October 1988
- journal article
- research article
- Vol. 38-2 (10) , 1442-1445
Abstract
The characteristics of the .alpha.2-adrenoceptor binding property of moxonidine (4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine, BDF 5895), a newly developed centrally acting antihypertensive agent, was investigated in receptor binding assays using [3H]-rauwolscine bound to rat cortex membranes. The results are as follows: 1. [3H]-Rauwolscine binds in a saturable manner to rat cerebral cortex membranes with a Bmax of 320 .+-. 50 fmol/mg of protein and KD of 1.7 .+-. 0.5 nmol/l. 2. The .alpha.2-adrenoceptor antagonist yohimbine competes with a Ki value of 8.0 nmol/l and slope factor close to unity. (-)-Norepinephrine competes with an overall Ki-value of 50 nmol/l and slope factor of 0.61. Mg2+ concentrations of 10 mmol/l in the presence of 0.1 mmol/l 3''-guanylimidodiphosphate (Gpp(NH)p) (Mg2+/Gpp(NH)p) do not affect the yohimbine inhibition curve, but increase the (-)-norepinephrine Ki value to 2.8 .mu.mol and the slope factor to unity. 3. Moxonidine competes with [3H]-rauwolscine binding with an overall Ki value of 460 nmol/l and slope factor of 0.72. Moxonidine binding inhibition was potentiated by Mg2+, but shifted to lower potency by Mg2+/Gpp(NH)p and 150 mmol/l NaCl. 4. Binding inhibition curves for (-)-norepinephrine and moxonidine fitted better to a 2-site model and could be interpreted in terms of high affinity site (with Ki value KH) and low affinity site (with Ki value KL). The effect of Mg2+/Gpp(NH)p and NaCl was to convert the high affinity sites to low affinity sites. 5. The Ki value of moxonidine to compete with [3H]-prozosin in cerebral cortex membranes is 36.5 .mu.mol/l. As KL for moxonidine is 3.7 .mu.mol/l, this means moxonidine is 10-fold selective for .alpha.2-adrenoceptors over .ALPHA.1-adrenoceptors.This publication has 10 references indexed in Scilit:
- DOPAMINE, ACTING THROUGH D-2 RECEPTORS, INHIBITS RAT STRIATAL ADENYLATE-CYCLASE BY A GTP-DEPENDENT PROCESS1986
- ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding.Journal of Biological Chemistry, 1984
- [3H]rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: Possible heterogeneity of α2-adrenoceptorsEuropean Journal of Pharmacology, 1982
- Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor.Journal of Biological Chemistry, 1982
- CHARACTERIZATION OF ALPHA-ADRENERGIC RECEPTOR SUBTYPES IN THE RAT RENAL CORTEX - DIFFERENTIAL REGULATION OF ALPHA-1-ADRENERGIC AND ALPHA-2-ADRENERGIC RECEPTORS BY GUANYL NUCLEOTIDES AND NA+1982
- [3H]rauwolscine (α-yohimbine): A specific antagonist radioligand for brain α2-adrenergic receptorsEuropean Journal of Pharmacology, 1981
- Solubilization of human platelet alpha-adrenergic receptors: evidence that agonist occupancy of the receptor stabilizes receptor--effector interactions.Proceedings of the National Academy of Sciences, 1981
- QUANTITATIVE-ANALYSIS OF BETA-ADRENERGIC-RECEPTOR INTERACTIONS - RESOLUTION OF HIGH AND LOW AFFINITY STATES OF THE RECEPTOR BY COMPUTER MODELING OF LIGAND-BINDING DATA1980
- AGONIST-SPECIFIC EFFECTS OF GUANINE-NUCLEOTIDES ON ALPHA-ADRENERGIC RECEPTORS IN HUMAN-PLATELETS1979
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951